A Phase II Randomized, Placebo-Controlled Clinical Trial of Purified Isoflavones in Modulating Steroid Hormones in Men Diagnosed With Localized Prostate Cancer

References

• American Cancer Society . 2006 . Cancer Facts and Figures, 2006 , Atlanta, GA : American Cancer Society .
   Google Scholar
• Kumar , N B , Cantor , A , Allen , K , Riccardi , D Besterman-Dahan , K . 2004 . The specific role of isoflavones in reducing prostate cancer risk . Prostate , 59 : 141 – 147 .
   PubMed Web of Science ®Google Scholar
• Bostwick , D G and Qian , J . 2004 . High-grade prostatic intraepithelial neoplasia . Mod Pathol , 17 : 360 – 379 .
   PubMed Web of Science ®Google Scholar
• Bostwick , D G , Burke , H B , Djakiew , D , Euling , S Ho , S M . 2004 . Human prostate cancer risk factors . Cancer Rev , 1 : 2371 – 2490 . (Suppl 10)
   Google Scholar
• Kelloff , G J , Leiberman , R , Steele , V E , Boone , C W Lubet , R A . 1999 . Chemoprevention of prostate cancer . Eur Urol , 35 : 342 – 350 .
   PubMed Web of Science ®Google Scholar
• Klotz , L . 2006 . Active surveillance versus radical treatment for favorable-risk localized prostate cancer . Curr Treat Options Oncol , 7 : 355 – 362 .
   PubMedGoogle Scholar
• Miller , D C , Gruber , S B , Hollenbeck , B K , Montie , J E and Wei , J T . 2006 . Incidence of initial local therapy among men with lower-risk prostate cancer in the United States . J Natl Cancer Inst , 98 : 1134 – 1141 .
   PubMedGoogle Scholar
• Adlercreutz , H , Houjo , H , Higashi , A , Fotsis , T Hämäläinen , E . 1991 . Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet . Am J Clin Nutr , 54 : 1093 – 1100 .
   PubMed Web of Science ®Google Scholar
• Jarred , R A , Keikha , M , Dowling , C , McPherson , S J Clare , A M . 2002 . Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones . Cancer Epidemiol Biomarkers Prev , 11 : 1689 – 1696 .
   PubMed Web of Science ®Google Scholar
• Chan , J M , Gann , P H and Giovannucci , E L . 2005 . Role of diet in prostate cancer development and progression . J Clin Oncol , 23 : 8152 – 8160 .
   PubMed Web of Science ®Google Scholar
• Blumenfeld , A J , Fleshner , N , Casselman , B and Trachtenberg , J . 2000 . Nutritional aspects of prostate cancer: a review . Can J Urol , 7 : 927 – 935 .
   PubMedGoogle Scholar
• Brossner , C , Petritsch , K , Fink , K , Auprich , M Madersbacher , S . 2004 . Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases . Urology , 64 : 707 – 711 .
   PubMed Web of Science ®Google Scholar
• Shimizu , H , Ross , R K , Bernstein , L , Yatani , R Henderson , B E . 1991 . Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County . Br J Cancer , 63 : 963 – 966 .
   PubMed Web of Science ®Google Scholar
• Morton , M S , Chan , P S , Cheng , C , Blacklock , N Matos-Ferreira , A . 1997 . Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom . Prostate , 32 : 122 – 128 .
   PubMed Web of Science ®Google Scholar
• Fotsis , T , Pepper , M , Adlecruetz , H , Hase , T Monttesano , R . 1995 . Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in Vitro angiogenesis . J Nutr , 125 : 790 – 797 .
   PubMed Web of Science ®Google Scholar
• Messina , M and Barnes , S . 1991 . The role of soy products in reducing risk of cancer . J Natl Cancer Inst , 83 : 541 – 546 .
   PubMed Web of Science ®Google Scholar
• Bemis , D L , Capodice , J L , Desai , M , Buttyan , R and Katz , A E . 2001 . A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo . Clin Cancer Res , 10 : 5282 – 5292 .
   Web of Science ®Google Scholar
• Jagadeesh , S , Kyo , S and Banerjee , P P . 2006 . Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells . Cancer Res , 66 : 2107 – 2115 .
   PubMed Web of Science ®Google Scholar
• Ouchi , H , Ishiguro , H , Ikeda , N , Hori , M Kubota , Y . 2005 . Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity . Int J Urol , 12 : 73 – 80 .
   PubMed Web of Science ®Google Scholar
• Adlercreutz , H , Mousavi , Y , Clark , J , Höckerstedt , K Hamalainen , E . 1992 . Dietary phytoestrogens and cancer: in vitro and in vivo studies . J Steroid Biochem Mol Biol , 41 : 331 – 337 .
   PubMed Web of Science ®Google Scholar
• Skogseth , H , Larsson , E and Halgunset , J . 2006 . The invasive behaviour of prostatic cancer cells is suppressed by inhibitors of tyrosine kinase . APMIS , 114 : 61 – 66 .
   PubMed Web of Science ®Google Scholar
• Huang , X , Chen , S , Xu , L , Liu , Y Deb , D K . 2005 . Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells . Cancer Res , 65 : 3470 – 3478 .
   PubMed Web of Science ®Google Scholar
• Li , Y , Kucuk , O , Hussain , M , Abrams , J Cher , M L . 2006 . Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer . Cancer Res , 66 : 4816 – 4825 .
   PubMed Web of Science ®Google Scholar
• Handayani , R , Rice , L , Cui , Y , Medrano , T A Samedi , V G . 2006 . Soy isoflavones alter expression of genes associated with cancer progression, including interleukin-8, in androgen-independent PC-3 human prostate cancer cells . J Nutr , 136 : 75 – 82 .
   PubMed Web of Science ®Google Scholar
• Raschke , M , Rowland , I R , Magee , P J and Pool-Zobel , B L . 2006 . Genistein protects prostate cells against hydrogen peroxide-induced DNA damage and induces expression of genes involved in the defense against oxidative stress . Carcinogenesis , 27 : 2322 – 2330 .
   PubMed Web of Science ®Google Scholar
• Kazi , A , Daniel , K G , Smith , D M , Kumar , N B and Dou , Q P . 2003 . Inhibition of the proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein . Biochem Pharmacol , 66 : 965 – 976 .
   PubMed Web of Science ®Google Scholar
• Barnes , S . 1995 . Effect of genistein on in vitro and in vivo models of cancer . J Nutr , 125 : 777s – 783s .
   PubMed Web of Science ®Google Scholar
• Adlercreutz , H , Mazur , W , Bartels , P , Elomaa , V Watanabe , S . 2000 . Phytoestrogens and prostate disease . J Nutr , 130 : 658S – 659S .
   PubMed Web of Science ®Google Scholar
• Parsons , J K , Carter , H B , Platz , E A , Wright , E J Landis , P . 2005 . Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy . Cancer Epidemiol Biomarkers Prev , 14 : 2257 – 2260 .
   PubMed Web of Science ®Google Scholar
• Carruba , G . 2006 . Estrogens and mechanisms of prostate cancer progression . Ann NY Acad Sci , 1089 : 201 – 217 .
   PubMed Web of Science ®Google Scholar
• Hempstock , J , Kavanagh , J P and George , N JR . 1998 . Growth inhibition of prostate cell lines in vitro by phytoestrogens . Br J Urol , 82 : 560 – 563 .
   PubMedGoogle Scholar
• Schleicher , R , Zheng , M , Zhang , M and Lamartiniere , C A . . Genistein inhibition in prostate cancer cell growth and metastasis in vivo . Proceedings of the 2nd International Symposium on the Role of Soy in Preventing and Treating Chronic Disease . Belgium.
   Google Scholar
• Fischer , L , Mahoney , C , Jeffcoat , A R , Koch , M A Thomas , B E . 2004 . Clinical characteristics and pharmacokinetics of purified soy isoflavones: multiple-dose administration to men with prostate neoplasia . Nutr Cancer , 48 : 160 – 170 .
   PubMed Web of Science ®Google Scholar
• Busby , M G , Jeffcoat , A R , Bloedon , L T , Koch , M A Black , T . 2002 . Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men . Am J Clin Nutr , 75 : 126 – 136 .
   PubMed Web of Science ®Google Scholar
• Hussain , M , Banerjee , M , Sarkar , F H , Djuric , Z Pollak , M N . 2003 . Soy isoflavones in the treatment of prostate cancer . Nutr Cancer , 47 : 111 – 117 .
   PubMed Web of Science ®Google Scholar
• Papaconstantinou , C and Krischer , J P . 1995 . An automated patient registration and treatment randomization system . J Med Syst , 19 : 445 – 456 .
   PubMedGoogle Scholar
• Kano , M , Takayanagi , T , Harada , K , Sawada , S and Ishikawa , F . 2006 . Bioavailability of isoflavones after ingestion of soy beverages in healthy adults . J Nutr , 136 : 2291 – 2296 .
   PubMed Web of Science ®Google Scholar
• Cassidy , A . 2006 . Factors affecting the bioavailability of soy isoflavones in humans . J AOAC Int , 89 : 1182 – 1188 .
   PubMed Web of Science ®Google Scholar
• Anupongsanugool , E , Teekachunhatean , S , Rojanasthien , N , Pongsatha , S and Sangdee , C . Pharmacokinetics of isoflavones, daidzein and genistein, after ingestion of soy beverage compared with soy extract capsules in postmenopausal Thai women . BMC Clin Pharmacol , 5 2
   PubMedGoogle Scholar
• Setchell , K D , Brown , N M , Zimmer-Nechemias , L , Brashear , W T Wolfe , B E . 2002 . Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability . Am J Clin Nutr , 76 : 447 – 453 .
   PubMed Web of Science ®Google Scholar